Company / Income Tax per Share
Xenon Pharmaceuticals Inc. Income Tax per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.01
FY2025
5-year range
-$0.05 / $0.01
FY2021-FY2025
Trend
+124.4%
vs FY2024
Sector context
#72 of 201
Health Care
What the data says
At $0.01, Xenon Pharmaceuticals Inc.'s income tax per share ranks #130 of 201 in the Health Care sector. Income Tax per Share returned to growth in FY2025 after 2 years of decline, reaching $0.01.
Based on SEC 10-K filings.
0.01 in FY2025 with a 3-year CAGR of +87.4%.
Increased from $-0.00 to $0.01 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +87.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#130 of 201 in Health CareTop 64% of 201This company $0.01 Sector average $1.35
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 124.4% year-over-year.
- Ranks #72 out of 201 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +124.4% |
| FY2024 | -$0.05 | -1102.5% |
| FY2023 | -$0.00 | -324.0% |
| FY2022 | $0.00 | +1517.2% |
| FY2021 | -$0.00 | +98.2% |
| FY2020 | -$0.01 | -739.1% |
| FY2019 | -$0.00 | +33.5% |
| FY2018 | -$0.00 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026